Bacterial Meningitis

Article Type
Changed
Display Headline
Bacterial Meningitis

Perhaps no admission causes so much consternation and dread amongst caregivers and families as a case of suspected bacterial meningitis. Will the patient live? What infection control precautions are necessary? And, perhaps most urgently, do I need antibiotic prophylaxis? In this article I answer the questions hospitalists most often need to address in such circumstances.

1. Who should have a head CT prior to lumbar puncture (LP) for suspected meningitis? Patients with immunocompromise, papilledema, preexisting CNS disease, new onset seizures, altered level of consciousness, and focal neurological findings should have a head CT prior to LP.1 While herniation is rare after LP for purulent meningitis, patients with increased intracranial pressure at risk for herniation often have normal head CT scans. Therefore, herniation may be an uncommon but unpredictable complication of LP in this setting. The cause-and-effect relationship of herniation and LP has also been questioned.

2. Are there any cerebrospinal fluid (CSF) findings that exclude bacterial meningitis? A number of CSF findings make bacterial meningitis quite likely, including total leukocyte counts of more than 2,000/mm3, a positive gram stain, or very low CSF glucose. It is difficult, if not impossible, however, to exclude bacterial meningitis in patients with any degree of CSF pleocytosis. For example, 10% of patients with bacterial meningitis have less than 100 WBCs/mm3 in CSF, and 10% have lymphocyte predominance at presentation. Therefore, the safest course of action when bacterial meningitis is suspected on clinical grounds and CSF pleocytosis is present is to continue antibiotics until results of CSF cultures are available.

3. Which patients with suspected or proven meningitis should receive steroids? Steroids reduce neurologic damage from the inflammatory surge provoked by antibiotic-induced pneumococcal lysis. In a large European trial, dexamethasone given in 10-mg doses every six hours for four days (before or with the first dose of antibiotics) reduced mortality in pneumococcal meningitis.2 Benefits were not seen in patients with bacterial meningitis from other pathogens. Dexamethasone can be safely stopped as soon as pneumococcal meningitis is excluded.

4. How soon should patients receive antibiotics? When bacterial meningitis is likely, antibiotics should be given immediately, prior to imaging studies and lumbar puncture. In patients with a lower clinical likelihood of bacterial meningitis, antibiotics can be deferred, awaiting the results of diagnostic studies.

5. What empiric antibiotic therapy is appropriate? Adults 18-50 with suspected bacterial meningitis should receive therapy directed against Streptococcus pneumoniae and Neisseria meningitidis. Vancomycin should be dosed to achieve a relatively high trough level of 15-20 mcg/mL. For a 70-kg adult male with normal renal function, doses of vancomycin given at the rate of 1.5 gm IV every 12 hours and ceftriaxone at 2 gm IV every 12 hours are appropriate. Adults over 50, alcoholics, and immunocompromised adults of any age should also receive ampicillin doses of 2 gm IV every four hours to cover Listeria, in addition to vancomycin and ceftriaxone.3,4

6. What infection control precautions are required? Meningococcal meningitis patients should be placed on droplet precautions (private room, mask for all entering the room) until they have completed 24 hours of appropriate antibiotic therapy. Negative pressure ventilation is not required. Patients with pneumococcal or viral meningitis do not require isolation.

7. Who needs antibiotic prophylaxis after patient exposure? Chemoprophylaxis is overprescribed after exposures to patients with meningococcal meningitis. The only social contacts who should receive prophylaxis are household contacts, childcare contacts, and people who have had direct exposure to the patient’s oral secretions through actions such as kissing or sharing utensils or toothbrushes. The only healthcare workers requiring chemoprophylaxis are those who performed mouth-to-mouth resuscitation or any staff who were unmasked during intubation or suctioning of a patient. Regimens for chemoprophylaxis in adults include ciprofloxacin, 500 mg taken orally as a single dose, rifampin taken in doses of 600 mg twice daily for two days, or 250 mg of ceftriaxone, given intramuscularly. Ceftriaxone is preferred for pregnant women. Chemoprophylaxis is unnecessary after exposure to patients with pneumococcal or viral meningitis.

 

 

8. What is the significance of arthritis after meningococcal meningitis? A significant number of patients with meningococcal disease develop inflammatory polyarthritis about a week after the onset of infection. In most cases, this is a sterile, immune complex phenomenon that responds to anti-inflammatory therapy. If joint effusions are present, they should be aspirated to exclude septic arthritis and crystalline arthritis. TH

Dr. Ross is a hospitalist at Brigham and Women’s Hospital (Boston) and a fellow of the Infectious Diseases Society of America.

References

  1. Hasbun R, Abrahams J, Jekel J, et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001 Dec 13;345(24):1727-1733.
  2. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. European dexamethasone in adulthood bacterial meningitis. N Engl J Med. 2002;347(20):1549-156.
  3. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-1284.
  4. van de Beek D, de Gans J, Tunkel AR, et al. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006 Jan 5;354(1):44-53.
Issue
The Hospitalist - 2006(09)
Publications
Topics
Sections

Perhaps no admission causes so much consternation and dread amongst caregivers and families as a case of suspected bacterial meningitis. Will the patient live? What infection control precautions are necessary? And, perhaps most urgently, do I need antibiotic prophylaxis? In this article I answer the questions hospitalists most often need to address in such circumstances.

1. Who should have a head CT prior to lumbar puncture (LP) for suspected meningitis? Patients with immunocompromise, papilledema, preexisting CNS disease, new onset seizures, altered level of consciousness, and focal neurological findings should have a head CT prior to LP.1 While herniation is rare after LP for purulent meningitis, patients with increased intracranial pressure at risk for herniation often have normal head CT scans. Therefore, herniation may be an uncommon but unpredictable complication of LP in this setting. The cause-and-effect relationship of herniation and LP has also been questioned.

2. Are there any cerebrospinal fluid (CSF) findings that exclude bacterial meningitis? A number of CSF findings make bacterial meningitis quite likely, including total leukocyte counts of more than 2,000/mm3, a positive gram stain, or very low CSF glucose. It is difficult, if not impossible, however, to exclude bacterial meningitis in patients with any degree of CSF pleocytosis. For example, 10% of patients with bacterial meningitis have less than 100 WBCs/mm3 in CSF, and 10% have lymphocyte predominance at presentation. Therefore, the safest course of action when bacterial meningitis is suspected on clinical grounds and CSF pleocytosis is present is to continue antibiotics until results of CSF cultures are available.

3. Which patients with suspected or proven meningitis should receive steroids? Steroids reduce neurologic damage from the inflammatory surge provoked by antibiotic-induced pneumococcal lysis. In a large European trial, dexamethasone given in 10-mg doses every six hours for four days (before or with the first dose of antibiotics) reduced mortality in pneumococcal meningitis.2 Benefits were not seen in patients with bacterial meningitis from other pathogens. Dexamethasone can be safely stopped as soon as pneumococcal meningitis is excluded.

4. How soon should patients receive antibiotics? When bacterial meningitis is likely, antibiotics should be given immediately, prior to imaging studies and lumbar puncture. In patients with a lower clinical likelihood of bacterial meningitis, antibiotics can be deferred, awaiting the results of diagnostic studies.

5. What empiric antibiotic therapy is appropriate? Adults 18-50 with suspected bacterial meningitis should receive therapy directed against Streptococcus pneumoniae and Neisseria meningitidis. Vancomycin should be dosed to achieve a relatively high trough level of 15-20 mcg/mL. For a 70-kg adult male with normal renal function, doses of vancomycin given at the rate of 1.5 gm IV every 12 hours and ceftriaxone at 2 gm IV every 12 hours are appropriate. Adults over 50, alcoholics, and immunocompromised adults of any age should also receive ampicillin doses of 2 gm IV every four hours to cover Listeria, in addition to vancomycin and ceftriaxone.3,4

6. What infection control precautions are required? Meningococcal meningitis patients should be placed on droplet precautions (private room, mask for all entering the room) until they have completed 24 hours of appropriate antibiotic therapy. Negative pressure ventilation is not required. Patients with pneumococcal or viral meningitis do not require isolation.

7. Who needs antibiotic prophylaxis after patient exposure? Chemoprophylaxis is overprescribed after exposures to patients with meningococcal meningitis. The only social contacts who should receive prophylaxis are household contacts, childcare contacts, and people who have had direct exposure to the patient’s oral secretions through actions such as kissing or sharing utensils or toothbrushes. The only healthcare workers requiring chemoprophylaxis are those who performed mouth-to-mouth resuscitation or any staff who were unmasked during intubation or suctioning of a patient. Regimens for chemoprophylaxis in adults include ciprofloxacin, 500 mg taken orally as a single dose, rifampin taken in doses of 600 mg twice daily for two days, or 250 mg of ceftriaxone, given intramuscularly. Ceftriaxone is preferred for pregnant women. Chemoprophylaxis is unnecessary after exposure to patients with pneumococcal or viral meningitis.

 

 

8. What is the significance of arthritis after meningococcal meningitis? A significant number of patients with meningococcal disease develop inflammatory polyarthritis about a week after the onset of infection. In most cases, this is a sterile, immune complex phenomenon that responds to anti-inflammatory therapy. If joint effusions are present, they should be aspirated to exclude septic arthritis and crystalline arthritis. TH

Dr. Ross is a hospitalist at Brigham and Women’s Hospital (Boston) and a fellow of the Infectious Diseases Society of America.

References

  1. Hasbun R, Abrahams J, Jekel J, et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001 Dec 13;345(24):1727-1733.
  2. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. European dexamethasone in adulthood bacterial meningitis. N Engl J Med. 2002;347(20):1549-156.
  3. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-1284.
  4. van de Beek D, de Gans J, Tunkel AR, et al. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006 Jan 5;354(1):44-53.

Perhaps no admission causes so much consternation and dread amongst caregivers and families as a case of suspected bacterial meningitis. Will the patient live? What infection control precautions are necessary? And, perhaps most urgently, do I need antibiotic prophylaxis? In this article I answer the questions hospitalists most often need to address in such circumstances.

1. Who should have a head CT prior to lumbar puncture (LP) for suspected meningitis? Patients with immunocompromise, papilledema, preexisting CNS disease, new onset seizures, altered level of consciousness, and focal neurological findings should have a head CT prior to LP.1 While herniation is rare after LP for purulent meningitis, patients with increased intracranial pressure at risk for herniation often have normal head CT scans. Therefore, herniation may be an uncommon but unpredictable complication of LP in this setting. The cause-and-effect relationship of herniation and LP has also been questioned.

2. Are there any cerebrospinal fluid (CSF) findings that exclude bacterial meningitis? A number of CSF findings make bacterial meningitis quite likely, including total leukocyte counts of more than 2,000/mm3, a positive gram stain, or very low CSF glucose. It is difficult, if not impossible, however, to exclude bacterial meningitis in patients with any degree of CSF pleocytosis. For example, 10% of patients with bacterial meningitis have less than 100 WBCs/mm3 in CSF, and 10% have lymphocyte predominance at presentation. Therefore, the safest course of action when bacterial meningitis is suspected on clinical grounds and CSF pleocytosis is present is to continue antibiotics until results of CSF cultures are available.

3. Which patients with suspected or proven meningitis should receive steroids? Steroids reduce neurologic damage from the inflammatory surge provoked by antibiotic-induced pneumococcal lysis. In a large European trial, dexamethasone given in 10-mg doses every six hours for four days (before or with the first dose of antibiotics) reduced mortality in pneumococcal meningitis.2 Benefits were not seen in patients with bacterial meningitis from other pathogens. Dexamethasone can be safely stopped as soon as pneumococcal meningitis is excluded.

4. How soon should patients receive antibiotics? When bacterial meningitis is likely, antibiotics should be given immediately, prior to imaging studies and lumbar puncture. In patients with a lower clinical likelihood of bacterial meningitis, antibiotics can be deferred, awaiting the results of diagnostic studies.

5. What empiric antibiotic therapy is appropriate? Adults 18-50 with suspected bacterial meningitis should receive therapy directed against Streptococcus pneumoniae and Neisseria meningitidis. Vancomycin should be dosed to achieve a relatively high trough level of 15-20 mcg/mL. For a 70-kg adult male with normal renal function, doses of vancomycin given at the rate of 1.5 gm IV every 12 hours and ceftriaxone at 2 gm IV every 12 hours are appropriate. Adults over 50, alcoholics, and immunocompromised adults of any age should also receive ampicillin doses of 2 gm IV every four hours to cover Listeria, in addition to vancomycin and ceftriaxone.3,4

6. What infection control precautions are required? Meningococcal meningitis patients should be placed on droplet precautions (private room, mask for all entering the room) until they have completed 24 hours of appropriate antibiotic therapy. Negative pressure ventilation is not required. Patients with pneumococcal or viral meningitis do not require isolation.

7. Who needs antibiotic prophylaxis after patient exposure? Chemoprophylaxis is overprescribed after exposures to patients with meningococcal meningitis. The only social contacts who should receive prophylaxis are household contacts, childcare contacts, and people who have had direct exposure to the patient’s oral secretions through actions such as kissing or sharing utensils or toothbrushes. The only healthcare workers requiring chemoprophylaxis are those who performed mouth-to-mouth resuscitation or any staff who were unmasked during intubation or suctioning of a patient. Regimens for chemoprophylaxis in adults include ciprofloxacin, 500 mg taken orally as a single dose, rifampin taken in doses of 600 mg twice daily for two days, or 250 mg of ceftriaxone, given intramuscularly. Ceftriaxone is preferred for pregnant women. Chemoprophylaxis is unnecessary after exposure to patients with pneumococcal or viral meningitis.

 

 

8. What is the significance of arthritis after meningococcal meningitis? A significant number of patients with meningococcal disease develop inflammatory polyarthritis about a week after the onset of infection. In most cases, this is a sterile, immune complex phenomenon that responds to anti-inflammatory therapy. If joint effusions are present, they should be aspirated to exclude septic arthritis and crystalline arthritis. TH

Dr. Ross is a hospitalist at Brigham and Women’s Hospital (Boston) and a fellow of the Infectious Diseases Society of America.

References

  1. Hasbun R, Abrahams J, Jekel J, et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001 Dec 13;345(24):1727-1733.
  2. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. European dexamethasone in adulthood bacterial meningitis. N Engl J Med. 2002;347(20):1549-156.
  3. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-1284.
  4. van de Beek D, de Gans J, Tunkel AR, et al. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006 Jan 5;354(1):44-53.
Issue
The Hospitalist - 2006(09)
Issue
The Hospitalist - 2006(09)
Publications
Publications
Topics
Article Type
Display Headline
Bacterial Meningitis
Display Headline
Bacterial Meningitis
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

Hyponatremia and the Role of Vasopressin

Article Type
Changed
Display Headline
Hyponatremia and the Role of Vasopressin
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Publications
Topics
Page Number
S1-S33
Sections
Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Page Number
S1-S33
Page Number
S1-S33
Publications
Publications
Topics
Article Type
Display Headline
Hyponatremia and the Role of Vasopressin
Display Headline
Hyponatremia and the Role of Vasopressin
Sections
Citation Override
Cleveland Clinic Journal of Medicine 2006 September;73(9 suppl 3):S1-S33
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Hyponatremia: More to the story than disordered sodium homeostasis

Article Type
Changed
Display Headline
Hyponatremia: More to the story than disordered sodium homeostasis
Article PDF
Author and Disclosure Information

Phillip Hall, MD
Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH

Publications
Page Number
S2-S3
Author and Disclosure Information

Phillip Hall, MD
Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH

Author and Disclosure Information

Phillip Hall, MD
Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH

Article PDF
Article PDF
Related Articles
Page Number
S2-S3
Page Number
S2-S3
Publications
Publications
Article Type
Display Headline
Hyponatremia: More to the story than disordered sodium homeostasis
Display Headline
Hyponatremia: More to the story than disordered sodium homeostasis
Citation Override
Cleveland Clinic Journal of Medicine 2006 September;73(suppl 3):S2-S3
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Article PDF Media

Proceedings of the 2nd Annual Perioperative Medicine Summit

Article Type
Changed
Display Headline
Proceedings of the 2nd Annual Perioperative Medicine Summit

Supplement Co-Editors and Summit Co-Directors:
Amir K. Jaffer, MD, and Franklin A. Michota, Jr., MD

Summit Co-Directors:
Angela M. Bader, MD, and Raymond Borkowski, MD

Contents

Summit Faculty

Summit Program

IMPACT Consults

Does elevated blood pressure at the time of surgery increase perioperative cardiac risk?
Collin Kroen, MD

When is it appropriate to stop antiplatelet therapy in a patient with a drug-eluting stent prior to noncardiac surgery?
Anitha Rajamanickam, MD; Vaishali Singh, MD, MPH, MBA; and Ashish Aneja, MD

Should statins be discontinued preoperatively?
Paul J. Grant, MD, and Navin Kedia, DO

What is the appropriate means of perioperative risk assessment for patients with cirrhosis?
Brian Harte, MD

Who is at risk for developing acute renal failure after surgery?
Vesselin Dimov, MD; Ali Usmani, MD; Saira Noor, MD; and Ajay Kumar, MD

Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin?
Ajay Kumar, MD, and Vesselin Dimov, MD

Obstructive sleep apnea: What to do in the surgical patient?
Roop Kaw, MD, and Joseph Golish, MD

What is the optimal venous thromboembolism prophylaxis for patients undergoing bariatric surgery?
David V. Gugliotti, MD

Do hip fractures need to be repaired withing 24 hours of injury?
Christopher M. Whinney, MD

Is postoperative atrial fibrillation in patients undergoing noncardiothoracic surgery an important problem?
Ashish Aneja, MD, and Wassim H. Fares, MD

How can postoperative ileus be prevented and treated?
Vaishali Singh, MD, MPH, MBA

Abstracts

Oral Abstracts

Is discontinuation of antiplatelet therapy after 6 months safe in patients with drug-eluting stents undergoing noncardiac surgery?
Mihir Bakhru, Wael Saber, Daniel Brotman, Deepak Bhatt, Ashish Aneja, Katherina Tillan-Martinez, and Amir Jaffer

Initiating a preoperative cardiac risk assessment quality improvement program: The hurdles to changing traditional paradigms
Eric Hixson, Karl McCleary, Vikram Kashyap, Vaishali Singh, Brian Harte, Ashish Aneja, Brian Parker, Raymond Borkowski, Walter Maurer, Venkatesh Krishnamurthi, Sue Vitagliano, Jacqueline Matthews, Linda Vopat, Michael Henderson, and Amir Jaffer

Impact of a preoperative medical clinic on operating room cancellation rates in orthopedic surgery
Peter Kallas, Anjali Desai, and Jeanette Bauer

Poster Abstracts

Innovations in Perioperative Medicine

Abstract 1: Best safety practices to prevent postoperative myocardial infarction

Abstract 2: Blog web site as a new educational and promotional medium in perioperative medicine

Abstract 3: Development of a validated questionnaire: The satisfaction with general anesthesia scale

Abstract 4: Perioperative medicine and pain: A required advanced core clerkship for third-year medical students

Abstract 5: Optimal administration of perioperative antibiotics using system redesign

Abstract 6: Blood conservation protocol with erythropoietin in the preoperative period of joint replacement surgery

Abstract 7: Evolution of the nurse practitioner (NP) role in the Center for Preoperative Evaluation (CPE) at Brigham and Women's Hospital

Abstract 8: Development and implementation of a web site for the Center for Preoperative Evaluation (CPE)

Abstract 9: Patient education tool for the preoperative process and the role of the medical consultant

Abstract 10: The internal medicine perioperative assessment center: An innovation in the perioperative management of medical comorbidities at a comprehensive cancer center

Abstract 11: PAC collaborative practice model

Abstract 12: Development and implementation of beta-blocker recommendation

Abstract 13: Development of pre-procedure consult services

Perioperative Clinical Vignettes

Abstract 14: Isolated left bundle branch block in a patient undergoing elective noncardiac surgery

Abstract 15: Avoiding delirium

Abstract 16: Cardiac sarcoma—the role of multimodality cardiovascular imaging

Abstract 17: Asymptomatic bacteriuria before nonprosthetic joint surgery

Abstract 18: Negative T waves on the preoperative electrocardiogram—a cause for worry?

Abstract 19: Preoperative hypokalemia

Abstract 20: Preoperative evaluation can aid in the diagnosis of CAD and risk assessment and management

Research in Perioperative Medicine

Abstract 21: Needs analysis for the development of a preoperative clinic protocol for perioperative beta-blockade

Abstract 22: Improving efficiency in a preoperative clinic

Abstract 23: Formalized preoperative assessment for noncardiac surgery at a large tertiary care medical center leads to higher rates of perioperative beta-blocker use

Abstract 24: Insulin errors in hospitalized patients

Abstract 25: A survey of perioperative beta-blockade at a comprehensive cancer center

Abstract 26: Risk factors for long-term mortality among heart failure patients after elective major noncardiac surgery

Index of Authors and Presenters

 

Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Publications
Topics
Page Number
S1-S36
Sections
Article PDF
Article PDF

Supplement Co-Editors and Summit Co-Directors:
Amir K. Jaffer, MD, and Franklin A. Michota, Jr., MD

Summit Co-Directors:
Angela M. Bader, MD, and Raymond Borkowski, MD

Contents

Summit Faculty

Summit Program

IMPACT Consults

Does elevated blood pressure at the time of surgery increase perioperative cardiac risk?
Collin Kroen, MD

When is it appropriate to stop antiplatelet therapy in a patient with a drug-eluting stent prior to noncardiac surgery?
Anitha Rajamanickam, MD; Vaishali Singh, MD, MPH, MBA; and Ashish Aneja, MD

Should statins be discontinued preoperatively?
Paul J. Grant, MD, and Navin Kedia, DO

What is the appropriate means of perioperative risk assessment for patients with cirrhosis?
Brian Harte, MD

Who is at risk for developing acute renal failure after surgery?
Vesselin Dimov, MD; Ali Usmani, MD; Saira Noor, MD; and Ajay Kumar, MD

Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin?
Ajay Kumar, MD, and Vesselin Dimov, MD

Obstructive sleep apnea: What to do in the surgical patient?
Roop Kaw, MD, and Joseph Golish, MD

What is the optimal venous thromboembolism prophylaxis for patients undergoing bariatric surgery?
David V. Gugliotti, MD

Do hip fractures need to be repaired withing 24 hours of injury?
Christopher M. Whinney, MD

Is postoperative atrial fibrillation in patients undergoing noncardiothoracic surgery an important problem?
Ashish Aneja, MD, and Wassim H. Fares, MD

How can postoperative ileus be prevented and treated?
Vaishali Singh, MD, MPH, MBA

Abstracts

Oral Abstracts

Is discontinuation of antiplatelet therapy after 6 months safe in patients with drug-eluting stents undergoing noncardiac surgery?
Mihir Bakhru, Wael Saber, Daniel Brotman, Deepak Bhatt, Ashish Aneja, Katherina Tillan-Martinez, and Amir Jaffer

Initiating a preoperative cardiac risk assessment quality improvement program: The hurdles to changing traditional paradigms
Eric Hixson, Karl McCleary, Vikram Kashyap, Vaishali Singh, Brian Harte, Ashish Aneja, Brian Parker, Raymond Borkowski, Walter Maurer, Venkatesh Krishnamurthi, Sue Vitagliano, Jacqueline Matthews, Linda Vopat, Michael Henderson, and Amir Jaffer

Impact of a preoperative medical clinic on operating room cancellation rates in orthopedic surgery
Peter Kallas, Anjali Desai, and Jeanette Bauer

Poster Abstracts

Innovations in Perioperative Medicine

Abstract 1: Best safety practices to prevent postoperative myocardial infarction

Abstract 2: Blog web site as a new educational and promotional medium in perioperative medicine

Abstract 3: Development of a validated questionnaire: The satisfaction with general anesthesia scale

Abstract 4: Perioperative medicine and pain: A required advanced core clerkship for third-year medical students

Abstract 5: Optimal administration of perioperative antibiotics using system redesign

Abstract 6: Blood conservation protocol with erythropoietin in the preoperative period of joint replacement surgery

Abstract 7: Evolution of the nurse practitioner (NP) role in the Center for Preoperative Evaluation (CPE) at Brigham and Women's Hospital

Abstract 8: Development and implementation of a web site for the Center for Preoperative Evaluation (CPE)

Abstract 9: Patient education tool for the preoperative process and the role of the medical consultant

Abstract 10: The internal medicine perioperative assessment center: An innovation in the perioperative management of medical comorbidities at a comprehensive cancer center

Abstract 11: PAC collaborative practice model

Abstract 12: Development and implementation of beta-blocker recommendation

Abstract 13: Development of pre-procedure consult services

Perioperative Clinical Vignettes

Abstract 14: Isolated left bundle branch block in a patient undergoing elective noncardiac surgery

Abstract 15: Avoiding delirium

Abstract 16: Cardiac sarcoma—the role of multimodality cardiovascular imaging

Abstract 17: Asymptomatic bacteriuria before nonprosthetic joint surgery

Abstract 18: Negative T waves on the preoperative electrocardiogram—a cause for worry?

Abstract 19: Preoperative hypokalemia

Abstract 20: Preoperative evaluation can aid in the diagnosis of CAD and risk assessment and management

Research in Perioperative Medicine

Abstract 21: Needs analysis for the development of a preoperative clinic protocol for perioperative beta-blockade

Abstract 22: Improving efficiency in a preoperative clinic

Abstract 23: Formalized preoperative assessment for noncardiac surgery at a large tertiary care medical center leads to higher rates of perioperative beta-blocker use

Abstract 24: Insulin errors in hospitalized patients

Abstract 25: A survey of perioperative beta-blockade at a comprehensive cancer center

Abstract 26: Risk factors for long-term mortality among heart failure patients after elective major noncardiac surgery

Index of Authors and Presenters

 

Supplement Co-Editors and Summit Co-Directors:
Amir K. Jaffer, MD, and Franklin A. Michota, Jr., MD

Summit Co-Directors:
Angela M. Bader, MD, and Raymond Borkowski, MD

Contents

Summit Faculty

Summit Program

IMPACT Consults

Does elevated blood pressure at the time of surgery increase perioperative cardiac risk?
Collin Kroen, MD

When is it appropriate to stop antiplatelet therapy in a patient with a drug-eluting stent prior to noncardiac surgery?
Anitha Rajamanickam, MD; Vaishali Singh, MD, MPH, MBA; and Ashish Aneja, MD

Should statins be discontinued preoperatively?
Paul J. Grant, MD, and Navin Kedia, DO

What is the appropriate means of perioperative risk assessment for patients with cirrhosis?
Brian Harte, MD

Who is at risk for developing acute renal failure after surgery?
Vesselin Dimov, MD; Ali Usmani, MD; Saira Noor, MD; and Ajay Kumar, MD

Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin?
Ajay Kumar, MD, and Vesselin Dimov, MD

Obstructive sleep apnea: What to do in the surgical patient?
Roop Kaw, MD, and Joseph Golish, MD

What is the optimal venous thromboembolism prophylaxis for patients undergoing bariatric surgery?
David V. Gugliotti, MD

Do hip fractures need to be repaired withing 24 hours of injury?
Christopher M. Whinney, MD

Is postoperative atrial fibrillation in patients undergoing noncardiothoracic surgery an important problem?
Ashish Aneja, MD, and Wassim H. Fares, MD

How can postoperative ileus be prevented and treated?
Vaishali Singh, MD, MPH, MBA

Abstracts

Oral Abstracts

Is discontinuation of antiplatelet therapy after 6 months safe in patients with drug-eluting stents undergoing noncardiac surgery?
Mihir Bakhru, Wael Saber, Daniel Brotman, Deepak Bhatt, Ashish Aneja, Katherina Tillan-Martinez, and Amir Jaffer

Initiating a preoperative cardiac risk assessment quality improvement program: The hurdles to changing traditional paradigms
Eric Hixson, Karl McCleary, Vikram Kashyap, Vaishali Singh, Brian Harte, Ashish Aneja, Brian Parker, Raymond Borkowski, Walter Maurer, Venkatesh Krishnamurthi, Sue Vitagliano, Jacqueline Matthews, Linda Vopat, Michael Henderson, and Amir Jaffer

Impact of a preoperative medical clinic on operating room cancellation rates in orthopedic surgery
Peter Kallas, Anjali Desai, and Jeanette Bauer

Poster Abstracts

Innovations in Perioperative Medicine

Abstract 1: Best safety practices to prevent postoperative myocardial infarction

Abstract 2: Blog web site as a new educational and promotional medium in perioperative medicine

Abstract 3: Development of a validated questionnaire: The satisfaction with general anesthesia scale

Abstract 4: Perioperative medicine and pain: A required advanced core clerkship for third-year medical students

Abstract 5: Optimal administration of perioperative antibiotics using system redesign

Abstract 6: Blood conservation protocol with erythropoietin in the preoperative period of joint replacement surgery

Abstract 7: Evolution of the nurse practitioner (NP) role in the Center for Preoperative Evaluation (CPE) at Brigham and Women's Hospital

Abstract 8: Development and implementation of a web site for the Center for Preoperative Evaluation (CPE)

Abstract 9: Patient education tool for the preoperative process and the role of the medical consultant

Abstract 10: The internal medicine perioperative assessment center: An innovation in the perioperative management of medical comorbidities at a comprehensive cancer center

Abstract 11: PAC collaborative practice model

Abstract 12: Development and implementation of beta-blocker recommendation

Abstract 13: Development of pre-procedure consult services

Perioperative Clinical Vignettes

Abstract 14: Isolated left bundle branch block in a patient undergoing elective noncardiac surgery

Abstract 15: Avoiding delirium

Abstract 16: Cardiac sarcoma—the role of multimodality cardiovascular imaging

Abstract 17: Asymptomatic bacteriuria before nonprosthetic joint surgery

Abstract 18: Negative T waves on the preoperative electrocardiogram—a cause for worry?

Abstract 19: Preoperative hypokalemia

Abstract 20: Preoperative evaluation can aid in the diagnosis of CAD and risk assessment and management

Research in Perioperative Medicine

Abstract 21: Needs analysis for the development of a preoperative clinic protocol for perioperative beta-blockade

Abstract 22: Improving efficiency in a preoperative clinic

Abstract 23: Formalized preoperative assessment for noncardiac surgery at a large tertiary care medical center leads to higher rates of perioperative beta-blocker use

Abstract 24: Insulin errors in hospitalized patients

Abstract 25: A survey of perioperative beta-blockade at a comprehensive cancer center

Abstract 26: Risk factors for long-term mortality among heart failure patients after elective major noncardiac surgery

Index of Authors and Presenters

 

Issue
Cleveland Clinic Journal of Medicine - 73(9)
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Page Number
S1-S36
Page Number
S1-S36
Publications
Publications
Topics
Article Type
Display Headline
Proceedings of the 2nd Annual Perioperative Medicine Summit
Display Headline
Proceedings of the 2nd Annual Perioperative Medicine Summit
Sections
Citation Override
Cleveland Clinic Journal of Medicine 2006 September;73(9 e-suppl 1):S1-S36
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Summit Program

Article Type
Changed
Display Headline
Summit Program
Article PDF
Publications
Page Number
S4
Article PDF
Article PDF
Page Number
S4
Page Number
S4
Publications
Publications
Article Type
Display Headline
Summit Program
Display Headline
Summit Program
Citation Override
Cleveland Clinic Journal of Medicine 2006 September;73(e-suppl 1):S4
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Article PDF Media

Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin?

Article Type
Changed
Display Headline
Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin?
Article PDF
Author and Disclosure Information

Ajay Kumar, MD
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, Cleveland, OH

Vesselin Dimov, MD
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, Cleveland, OH

Correspondence: Ajay Kumar, MD, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, 9500 Euclid Avenue, A13, Cleveland, OH 44195; kumara@ccf.org

Both authors reported that they have no commercial affiliations or financial interests that pose a potential conflict of interest with this article.

Publications
Page Number
S13-S15
Author and Disclosure Information

Ajay Kumar, MD
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, Cleveland, OH

Vesselin Dimov, MD
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, Cleveland, OH

Correspondence: Ajay Kumar, MD, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, 9500 Euclid Avenue, A13, Cleveland, OH 44195; kumara@ccf.org

Both authors reported that they have no commercial affiliations or financial interests that pose a potential conflict of interest with this article.

Author and Disclosure Information

Ajay Kumar, MD
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, Cleveland, OH

Vesselin Dimov, MD
Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, Cleveland, OH

Correspondence: Ajay Kumar, MD, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic, 9500 Euclid Avenue, A13, Cleveland, OH 44195; kumara@ccf.org

Both authors reported that they have no commercial affiliations or financial interests that pose a potential conflict of interest with this article.

Article PDF
Article PDF
Page Number
S13-S15
Page Number
S13-S15
Publications
Publications
Article Type
Display Headline
Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin?
Display Headline
Why treat anemia in the preoperative period of joint replacement surgery with erythropoietin?
Citation Override
Cleveland Clinic Journal of Medicine 2006 September;73(e-suppl 1):S13-S15
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Un-Gate On Date
Use ProPublica
CFC Schedule Remove Status
Article PDF Media

Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer.

Article Type
Changed
Display Headline
Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer
A perspective on the women's health study
Article PDF
Author and Disclosure Information

Julie E. Burning, ScD
Professor of Medicine, Harvard Medical School; Division of Preventive Medicine, Brigham and Women’s Hospital, Boston; principal investigator, Women’s Health Study

Address: Julie E. Buring, ScD, Division of Preventive Medicine, Brigham and Women’s Hospital, 900 Commonwealth Avenue East, Boston, MA 02215; e-mail jburing@rics.bwh.harvard.edu

Dr. Buring has received investigator-initiated research funding and support as Principal Investigator from the National Institutes of Health (the National Heart, Lung, and Blood Institute, the National Cancer Institute, and the National Institute of Aging) and Dow Corning Corporation; has received research support for pills and/or packaging from Bayer Health Care and the Natural Source Vitamin E Association; has received honoraria from Bayer for speaking engagements; and has served on a study’s external scientific advisory committee for Procter & Gamble.

This Medical Grand Rounds article is based on edited transcripts from a Heart Center Grand Rounds presentation at Cleveland Clinic. It was approved by the author but was not peer-reviewed.

Issue
Cleveland Clinic Journal of Medicine - 73(9)
Publications
Topics
Page Number
863-870
Sections
Author and Disclosure Information

Julie E. Burning, ScD
Professor of Medicine, Harvard Medical School; Division of Preventive Medicine, Brigham and Women’s Hospital, Boston; principal investigator, Women’s Health Study

Address: Julie E. Buring, ScD, Division of Preventive Medicine, Brigham and Women’s Hospital, 900 Commonwealth Avenue East, Boston, MA 02215; e-mail jburing@rics.bwh.harvard.edu

Dr. Buring has received investigator-initiated research funding and support as Principal Investigator from the National Institutes of Health (the National Heart, Lung, and Blood Institute, the National Cancer Institute, and the National Institute of Aging) and Dow Corning Corporation; has received research support for pills and/or packaging from Bayer Health Care and the Natural Source Vitamin E Association; has received honoraria from Bayer for speaking engagements; and has served on a study’s external scientific advisory committee for Procter & Gamble.

This Medical Grand Rounds article is based on edited transcripts from a Heart Center Grand Rounds presentation at Cleveland Clinic. It was approved by the author but was not peer-reviewed.

Author and Disclosure Information

Julie E. Burning, ScD
Professor of Medicine, Harvard Medical School; Division of Preventive Medicine, Brigham and Women’s Hospital, Boston; principal investigator, Women’s Health Study

Address: Julie E. Buring, ScD, Division of Preventive Medicine, Brigham and Women’s Hospital, 900 Commonwealth Avenue East, Boston, MA 02215; e-mail jburing@rics.bwh.harvard.edu

Dr. Buring has received investigator-initiated research funding and support as Principal Investigator from the National Institutes of Health (the National Heart, Lung, and Blood Institute, the National Cancer Institute, and the National Institute of Aging) and Dow Corning Corporation; has received research support for pills and/or packaging from Bayer Health Care and the Natural Source Vitamin E Association; has received honoraria from Bayer for speaking engagements; and has served on a study’s external scientific advisory committee for Procter & Gamble.

This Medical Grand Rounds article is based on edited transcripts from a Heart Center Grand Rounds presentation at Cleveland Clinic. It was approved by the author but was not peer-reviewed.

Article PDF
Article PDF
A perspective on the women's health study
A perspective on the women's health study
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Page Number
863-870
Page Number
863-870
Publications
Publications
Topics
Article Type
Display Headline
Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer
Display Headline
Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Imaging's roles in acute pancreatitis

Article Type
Changed
Display Headline
Imaging's roles in acute pancreatitis
Article PDF
Author and Disclosure Information

Tina Bolek, MD
Department of Diagnostic Radiology, Cleveland Clinic

Mark E. Baker, MD
Department of Diagnostic Radiology, Cleveland Clinic

R. Matthew Walsh, MD
Department of General Surgery, Cleveland Clinic

Address: Mark E. Baker, Department of Diagnostic Radiology, Hb6, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; bakerm@ccf.org

Issue
Cleveland Clinic Journal of Medicine - 73(9)
Publications
Topics
Page Number
857-862
Sections
Author and Disclosure Information

Tina Bolek, MD
Department of Diagnostic Radiology, Cleveland Clinic

Mark E. Baker, MD
Department of Diagnostic Radiology, Cleveland Clinic

R. Matthew Walsh, MD
Department of General Surgery, Cleveland Clinic

Address: Mark E. Baker, Department of Diagnostic Radiology, Hb6, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; bakerm@ccf.org

Author and Disclosure Information

Tina Bolek, MD
Department of Diagnostic Radiology, Cleveland Clinic

Mark E. Baker, MD
Department of Diagnostic Radiology, Cleveland Clinic

R. Matthew Walsh, MD
Department of General Surgery, Cleveland Clinic

Address: Mark E. Baker, Department of Diagnostic Radiology, Hb6, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; bakerm@ccf.org

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Page Number
857-862
Page Number
857-862
Publications
Publications
Topics
Article Type
Display Headline
Imaging's roles in acute pancreatitis
Display Headline
Imaging's roles in acute pancreatitis
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Newer antibiotics for serious gram-positive infections

Article Type
Changed
Display Headline
Newer antibiotics for serious gram-positive infections
Article PDF
Author and Disclosure Information

Thomas G. Fraser, MD
Department of Infectious Diseases, Cleveland Clinic

Christine Hansen, PharmD
Department of Pharmacy, Shands Hospital, Orlando, FL

Jennifer K. Long, PharmD
Department of Pharmacy, Cleveland Clinic

Address: Thomas G. Fraser, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail frasert@ccf.org

Dr. Fraser is a member of the Wyeth Emerging Pathogens speakers’ bureau.

Dr. Long is a member of the Cubist speakers’ bureau and the Pfizer speakers’ bureau. This manuscript was generated without outside funding.

Issue
Cleveland Clinic Journal of Medicine - 73(9)
Publications
Topics
Page Number
847-853
Sections
Author and Disclosure Information

Thomas G. Fraser, MD
Department of Infectious Diseases, Cleveland Clinic

Christine Hansen, PharmD
Department of Pharmacy, Shands Hospital, Orlando, FL

Jennifer K. Long, PharmD
Department of Pharmacy, Cleveland Clinic

Address: Thomas G. Fraser, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail frasert@ccf.org

Dr. Fraser is a member of the Wyeth Emerging Pathogens speakers’ bureau.

Dr. Long is a member of the Cubist speakers’ bureau and the Pfizer speakers’ bureau. This manuscript was generated without outside funding.

Author and Disclosure Information

Thomas G. Fraser, MD
Department of Infectious Diseases, Cleveland Clinic

Christine Hansen, PharmD
Department of Pharmacy, Shands Hospital, Orlando, FL

Jennifer K. Long, PharmD
Department of Pharmacy, Cleveland Clinic

Address: Thomas G. Fraser, MD, Department of Infectious Disease, S32, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail frasert@ccf.org

Dr. Fraser is a member of the Wyeth Emerging Pathogens speakers’ bureau.

Dr. Long is a member of the Cubist speakers’ bureau and the Pfizer speakers’ bureau. This manuscript was generated without outside funding.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Page Number
847-853
Page Number
847-853
Publications
Publications
Topics
Article Type
Display Headline
Newer antibiotics for serious gram-positive infections
Display Headline
Newer antibiotics for serious gram-positive infections
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Tending to the musculoskeletal problems of obesity

Article Type
Changed
Display Headline
Tending to the musculoskeletal problems of obesity
Article PDF
Author and Disclosure Information

Michele M. Hooper, MD, MS
Associate director of medical affairs, Amgen Inc, Thousand Oaks, CA

Address: Michele M. Hooper, MD, Amgen, One Amgen Center Drive, MS 27-1-D, Thousand Oaks, CA 91320; e-mail hooperm@amgen.com

Issue
Cleveland Clinic Journal of Medicine - 73(9)
Publications
Topics
Page Number
839-845
Sections
Author and Disclosure Information

Michele M. Hooper, MD, MS
Associate director of medical affairs, Amgen Inc, Thousand Oaks, CA

Address: Michele M. Hooper, MD, Amgen, One Amgen Center Drive, MS 27-1-D, Thousand Oaks, CA 91320; e-mail hooperm@amgen.com

Author and Disclosure Information

Michele M. Hooper, MD, MS
Associate director of medical affairs, Amgen Inc, Thousand Oaks, CA

Address: Michele M. Hooper, MD, Amgen, One Amgen Center Drive, MS 27-1-D, Thousand Oaks, CA 91320; e-mail hooperm@amgen.com

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Issue
Cleveland Clinic Journal of Medicine - 73(9)
Page Number
839-845
Page Number
839-845
Publications
Publications
Topics
Article Type
Display Headline
Tending to the musculoskeletal problems of obesity
Display Headline
Tending to the musculoskeletal problems of obesity
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media